×

JOIN OUR NEWSLETTER TO UNLOCK 20% OFF YOUR FIRST PURCHASE.

Sign up

Existing customer? Sign in

PrecisionHealth Genetic Report

Member
Name: Jane Doe
Member ID: 1234
Sex at Birth: Female
Date of Birth: 12/12/2000

Provider
Name: Dr. Smith
Address: 100 Burdell Dr, Atlanta, GA

Sample Collection
Specimen ID: 3456
Specimen Type: Saliva
Amount: >2mL
Collection Tube: DNA Genotek Oragene•DNA (OG-600)
Collected: 6/24/2024

Sequencing
Test ID: 78910
Test Type: WES
Depth: 100x
Quality: Satisfactory
Sequenced: 9/30/2024

Executive Summary - General Genetic Predisposition Report

Whole Exome Sequencing - Research Results

Mendelian Disorder Predictions

We did not predict any Mendelian Disorder associations.

Key Results

  • Predisposition to Diseases: The user has been predicted to have a predisposition for 46 diseases. Further steps may include more detailed risk assessments for specific conditions.
  • Carrier Status: The presence of certain genetic variants indicates the possibility of being a carrier for genetic conditions. It is recommended to request a Carrier Report for a detailed analysis of any hereditary conditions.
  • Treatment Recommendations: Based on the genetic findings, a personalized treatment approach may be beneficial. It is suggested to request a Treatment Report to guide medication and therapy options.
  • Next Steps: Schedule a consultation with your healthcare provider to review your results and to discuss the Carrier Report and Treatment Report, which will offer deeper insights into the genetic risks and potential treatment paths.

Please note: This is a sample report with sample data.

*Disclaimers: This report is intended for research use only and is not diagnostic. Please consult with a healthcare provider for diagnoses and next steps.

**Provider recommendation: Please consult a genetic counselor or healthcare provider for next steps. If you do not have a healthcare provider, GeneHealth can assist with matching you to one.

***Treatment explanation: We provide recommendations for compassionate use drugs in cases where traditional treatment options have been exhausted. Treatments are to be discussed with your healthcare provider.

Explore Genetic Insights

Summary

Diseases Found 46
High Risk 1
Medium Risk 43
Low Risk 2
Mutated Genes Found 21

Autoimmune Disorders :

The following diseases are associated with Autoimmune Disorders ::

Disease Predisposition
Immune System Diseases Medium
Autoimmune Diseases Medium
Connective Tissue Diseases Low
Demyelinating Autoimmune Diseases, Cns Low

Immune System Diseases

Immune system diseases can broadly be categorized into two types: autoimmune diseases and immunodeficiency diseases. The type of genetic transmission for these diseases can vary: 1. **Autoimmune Diseases**: These are often multifactorial, involving a combination of genetic predisposition and environmental factors. Specific autoimmune diseases can have different patterns of inheritance, including: - **Polygenic Inheritance**: Involves multiple genes (e.g., Type 1 Diabetes, Rheumatoid Arthritis). - **Monogenic Inheritance**: Involves a single gene (less common, e.g., Autoimmune Lymphoproliferative Syndrome). 2. **Immunodeficiency Diseases**: These are often caused by single-gene mutations and can follow various patterns of genetic transmission: - **Autosomal Recessive**: Both copies of the gene must be mutated (e.g., Severe Combined Immunodeficiency [SCID]). - **Autosomal Dominant**: Only one copy of the gene needs to be mutated (e.g., Hyper-IgE Syndrome). - **X-Linked Recessive**: The gene causing the disease is located on the X chromosome (e.g., X-Linked Agammaglobulinemia). Each immune system disease can have a specific genetic transmission pattern that influences its inheritance and manifestation.

Predisposition: Medium
Explanation of predisposition: We predict genetic risk by analyzing specific genetic variants within key genes associated with a condition. For each variant, we assess its impact on biological pathways that are known to influence the disease. The prediction takes into account both the clinical significance of each variant and the confidence in the prediction, which is determined by the quality and strength of the supporting scientific data and research.
Associated Genes
Gene Mutation Type Allele Confidence
SLC12A7 Deletion T/G Medium
ANK2 Deletion G/T Medium
ZFYVE9 Deletion C/C Medium
FOXD4 Substitution C/T Medium
ACAD9-DT Insertion G/G Medium
Population Frequency By Gene

Population frequency indicates how common a specific genetic variant is within a group of people, expressed as a percentage. For example, if a gene variant has a frequency of 20%, it means about 20 out of 100 individuals carry that variant. This information helps researchers understand the potential impact of genetic variants on health and traits within different populations.

Gene Frequency
SLC12A7 9%
ANK2 16%
ZFYVE9 12%
FOXD4 5%
ACAD9-DT 24%
Associated Pathways

A pathway refers to a series of biochemical reactions and interactions that occur within cells, allowing for communication between genes, proteins, and metabolites. These pathways are crucial for various physiological functions, including neurotransmission, hormone signaling, and metabolic processes, and can influence behaviors and health outcomes when disrupted by genetic mutations.

Pathway Type Effects
REACT:R-HSA-6805567 Adrenergic Receptor Signaling Influences inflammatory response
REACT:R-HSA-74160 Adrenergic Receptor Signaling Influences inflammatory response
REACT:R-HSA-76002 GABAergic Signaling Modulates metabolism and energy use
Possible Comobordities

Comorbidities are additional health conditions that often occur alongside a primary condition. For example, someone with ADHD may also have other related issues, such as anxiety or learning difficulties. These conditions are linked because they may share similar causes, such as genetics or brain chemistry, making it more likely for a person to experience both at the same time.

Gene Comorbidities Associated Mechanism
SLC12A7 Chronic Obstructive Pulmonary Disease (COPD) Hormonal imbalance
ANK2 Osteoporosis Metabolic dysregulation
ZFYVE9 Diabetes Chronic infection
FOXD4 Depression Cellular apoptosis
ACAD9-DT Osteoporosis Neurodegeneration

Recommendations for Medium Risk for Immune System Disease

  • Consultation: Schedule a follow-up consultation with a primary care provider or genetic counselor.
  • Monitoring: Regularly monitor your health for early signs of the condition associated with your predisposition.
  • Lifestyle Adjustments: Implement moderate lifestyle changes to mitigate risk.
  • Personalized Lifestyle Plan:
    • Maintain a balanced diet rich in whole foods, lean protein, and healthy fats.
    • Engage in regular physical activity, such as walking, swimming, or light strength training.
    • Incorporate stress management techniques like deep breathing exercises or light yoga.
    • Limit alcohol consumption and reduce exposure to pollutants.

    For additional guidance on managing your predisposition: See treatment options for immune system diseases.

Autoimmune Diseases

Uterine diseases encompass various conditions, including: 1. Uterine fibroids: Benign tumors composed of smooth muscle and fibrous tissue. 2. Endometriosis: Growth of endometrial tissue outside the uterus. 3. Uterine cancer (e.g., endometrial carcinoma): Malignancy in the lining of the uterus. 4. Adenomyosis: Endometrial tissue growing into the uterine muscle. Type of genetic transmission: Most uterine diseases do not follow a simple Mendelian pattern of inheritance. However, there may be genetic predispositions influenced by multiple genetic and environmental factors. For example, uterine fibroids and endometriosis have shown familial clustering, suggesting a hereditary component. Uterine cancer may also have a genetic basis, particularly when associated with hereditary cancer syndromes like Lynch syndrome.

Predisposition: Medium
Explanation of predisposition: We predict genetic risk by analyzing specific genetic variants within key genes associated with a condition. For each variant, we assess its impact on biological pathways that are known to influence the disease. The prediction takes into account both the clinical significance of each variant and the confidence in the prediction, which is determined by the quality and strength of the supporting scientific data and research.
Associated Genes
Gene Mutation Type Allele Confidence
PUM3 Insertion T/T Medium
ANK2 Insertion C/C High
MRPL36 Insertion G/G Medium
GSTM4 Frameshift A/C High
TMEM45A Frameshift T/T Medium
Population Frequency By Gene

Population frequency indicates how common a specific genetic variant is within a group of people, expressed as a percentage. For example, if a gene variant has a frequency of 20%, it means about 20 out of 100 individuals carry that variant. This information helps researchers understand the potential impact of genetic variants on health and traits within different populations.

Gene Frequency
PUM3 9%
ANK2 15%
MRPL36 1%
GSTM4 3%
TMEM45A 22%
Associated Pathways

A pathway refers to a series of biochemical reactions and interactions that occur within cells, allowing for communication between genes, proteins, and metabolites. These pathways are crucial for various physiological functions, including neurotransmission, hormone signaling, and metabolic processes, and can influence behaviors and health outcomes when disrupted by genetic mutations.

Pathway Type Effects
REACT:R-HSA-6805567 TGF-beta Signaling Pathway Controls cell differentiation
REACT:R-HSA-76002 Glutamatergic Transmission Involved in cell growth and survival
Possible Comobordities

Comorbidities are additional health conditions that often occur alongside a primary condition. For example, someone with ADHD may also have other related issues, such as anxiety or learning difficulties. These conditions are linked because they may share similar causes, such as genetics or brain chemistry, making it more likely for a person to experience both at the same time.

Gene Comorbidities Associated Mechanism
PUM3 Hypertension Metabolic dysregulation
ANK2 Depression Cellular apoptosis
MRPL36 Coronary Artery Disease Cellular apoptosis
GSTM4 Depression Hormonal imbalance
TMEM45A Diabetes Metabolic dysregulation

Recommendations for Medium Risk for Uterine Disease

  • Consultation: Schedule a follow-up consultation with a primary care provider or genetic counselor.
  • Monitoring: Regularly monitor your health for early signs of the condition associated with your predisposition.
  • Lifestyle Adjustments: Implement moderate lifestyle changes to mitigate risk.
  • Personalized Lifestyle Plan:
    • Maintain a balanced diet rich in whole foods, lean protein, and healthy fats.
    • Engage in regular physical activity, such as walking, swimming, or light strength training.
    • Incorporate stress management techniques like deep breathing exercises or light yoga.
    • Limit alcohol consumption and reduce exposure to pollutants.

    For additional guidance on managing your predisposition: See treatment options for Autoimmune Diseases.

Connective Tissue Diseases

Mixed connective tissue disease is an autoimmune disorder. It is not typically considered to have a direct genetic transmission; rather, it is believed to result from a combination of genetic predisposition and environmental factors.

Predisposition: Low
Explanation of predisposition: We predict genetic risk by analyzing specific genetic variants within key genes associated with a condition. For each variant, we assess its impact on biological pathways that are known to influence the disease. The prediction takes into account both the clinical significance of each variant and the confidence in the prediction, which is determined by the quality and strength of the supporting scientific data and research.
Associated Genes
Gene Mutation Type Allele Confidence
ZDHHC11 Deletion G/C High
ZNF518B Insertion C/C Medium
GSTM4 Deletion G/G Medium
PUM3 Inversion A/C Medium
GTPBP8 Deletion C/A High
Population Frequency By Gene

Population frequency indicates how common a specific genetic variant is within a group of people, expressed as a percentage. For example, if a gene variant has a frequency of 20%, it means about 20 out of 100 individuals carry that variant. This information helps researchers understand the potential impact of genetic variants on health and traits within different populations.

Gene Frequency
ZDHHC11 18%
ZNF518B 22%
GSTM4 15%
PUM3 3%
GTPBP8 8%
Associated Pathways

A pathway refers to a series of biochemical reactions and interactions that occur within cells, allowing for communication between genes, proteins, and metabolites. These pathways are crucial for various physiological functions, including neurotransmission, hormone signaling, and metabolic processes, and can influence behaviors and health outcomes when disrupted by genetic mutations.

Pathway Type Effects
REACT:R-HSA-6805567 Wnt Signaling Pathway Involved in cell growth and survival
REACT:R-HSA-76002 TGF-beta Signaling Pathway Critical for embryonic development
Possible Comobordities

Comorbidities are additional health conditions that often occur alongside a primary condition. For example, someone with ADHD may also have other related issues, such as anxiety or learning difficulties. These conditions are linked because they may share similar causes, such as genetics or brain chemistry, making it more likely for a person to experience both at the same time.

Gene Comorbidities Associated Mechanism
ZDHHC11 Asthma Hormonal imbalance
ZNF518B Depression Inflammation
GSTM4 Stroke Metabolic dysregulation
PUM3 Parkinson's Disease Oxidative stress
GTPBP8 Hypertension Mitochondrial impairment

Recommendations for Low Risk for Mixed Connective Tissue Disease

  • Consultation: Consider discussing results with a healthcare provider for general awareness.
  • Health Maintenance: Focus on maintaining overall health and well-being.
  • Personalized Lifestyle Plan:
    • Eat a diverse diet emphasizing fruits, vegetables, and whole grains.
    • Engage in consistent, low-impact physical activity like walking or gardening.
    • Prioritize sleep hygiene and ensure adequate rest.
    • Minimize exposure to environmental toxins and avoid smoking.

    For general wellness recommendations: Explore recommendations for Connective Tissue Diseases.

Demyelinating Autoimmune Diseases, Cns

Demyelinating diseases generally refer to a group of disorders characterized by damage to the myelin sheath of neurons. Some common types include Multiple Sclerosis (MS), Neuromyelitis Optica (NMO), and Acute Disseminated Encephalomyelitis (ADEM). Type of genetic transmission: The genetic component varies by specific demyelinating disease. For example, Multiple Sclerosis is considered to have a complex multifactorial genetic basis, meaning that it is influenced by multiple genetic and environmental factors rather than following a simple Mendelian inheritance pattern.

Predisposition: Low
Explanation of predisposition: We predict genetic risk by analyzing specific genetic variants within key genes associated with a condition. For each variant, we assess its impact on biological pathways that are known to influence the disease. The prediction takes into account both the clinical significance of each variant and the confidence in the prediction, which is determined by the quality and strength of the supporting scientific data and research.
Associated Genes
Gene Mutation Type Allele Confidence
PHACTR2 Deletion A/A Medium
TMEM45A Deletion A/G Medium
FOXD4 Substitution A/T Medium
MROH2B Substitution T/C Medium
ANK2 Duplication A/C Medium
Population Frequency By Gene

Population frequency indicates how common a specific genetic variant is within a group of people, expressed as a percentage. For example, if a gene variant has a frequency of 20%, it means about 20 out of 100 individuals carry that variant. This information helps researchers understand the potential impact of genetic variants on health and traits within different populations.

Gene Frequency
PHACTR2 9%
TMEM45A 17%
FOXD4 9%
MROH2B 6%
ANK2 4%
Associated Pathways

A pathway refers to a series of biochemical reactions and interactions that occur within cells, allowing for communication between genes, proteins, and metabolites. These pathways are crucial for various physiological functions, including neurotransmission, hormone signaling, and metabolic processes, and can influence behaviors and health outcomes when disrupted by genetic mutations.

Pathway Type Effects
REACT:R-HSA-6805567 Adrenergic Receptor Signaling Involved in cell growth and survival
Possible Comobordities

Comorbidities are additional health conditions that often occur alongside a primary condition. For example, someone with ADHD may also have other related issues, such as anxiety or learning difficulties. These conditions are linked because they may share similar causes, such as genetics or brain chemistry, making it more likely for a person to experience both at the same time.

Gene Comorbidities Associated Mechanism
PHACTR2 Hypertension Genetic predisposition
TMEM45A Depression Neurodegeneration
FOXD4 Coronary Artery Disease Immune system dysfunction
MROH2B Parkinson's Disease Metabolic dysregulation
ANK2 Diabetes Mitochondrial impairment

Recommendations for Low Risk for Demyelinating Disease

  • Consultation: Consider discussing results with a healthcare provider for general awareness.
  • Health Maintenance: Focus on maintaining overall health and well-being.
  • Personalized Lifestyle Plan:
    • Eat a diverse diet emphasizing fruits, vegetables, and whole grains.
    • Engage in consistent, low-impact physical activity like walking or gardening.
    • Prioritize sleep hygiene and ensure adequate rest.
    • Minimize exposure to environmental toxins and avoid smoking.

    For general wellness recommendations: Explore recommendations for demyelinating autoimmune diseases, cns.

Appendix

Mutated Genes Found

Diseases Found